Correlation Between Xilio Development and Poniard Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Xilio Development and Poniard Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Xilio Development and Poniard Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Xilio Development and Poniard Pharmaceuticals, you can compare the effects of market volatilities on Xilio Development and Poniard Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Xilio Development with a short position of Poniard Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Xilio Development and Poniard Pharmaceuticals.

Diversification Opportunities for Xilio Development and Poniard Pharmaceuticals

0.0

Correlation Coefficient

Xilio Development  Poniard Pharmaceuticals

Pay attention - limited upside

The 3 months correlation between Xilio and Poniard is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Xilio Development and Poniard Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Poniard Pharmaceuticals and Xilio Development is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Xilio Development are associated (or correlated) with Poniard Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Poniard Pharmaceuticals has no effect on the direction of Xilio Development i.e., Xilio Development and Poniard Pharmaceuticals go up and down completely randomly.

Pair Corralation between Xilio Development and Poniard Pharmaceuticals

If you would invest  74.00  in Xilio Development on September 3, 2024 and sell it today you would earn a total of  35.00  from holding Xilio Development or generate 47.3% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	1.56%
Values	Daily Returns

Xilio Development  vs.  Poniard Pharmaceuticals

Xilio Development

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Xilio Development are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady essential indicators, Xilio Development displayed solid returns over the last few months and may actually be approaching a breakup point.

Poniard Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Poniard Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Poniard Pharmaceuticals is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with Xilio Development and Poniard Pharmaceuticals

The main advantage of trading using opposite Xilio Development and Poniard Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Xilio Development position performs unexpectedly, Poniard Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Poniard Pharmaceuticals will offset losses from the drop in Poniard Pharmaceuticals' long position.

The idea behind Xilio Development and Poniard Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.